Related Experiment Videos
Duchenne muscular dystrophy
1Shriners Hospitals for Children, Portland, OR 97201, USA.
Abstract:
Duchenne muscular dystrophy is an X-linked disease of muscle caused by an absence of the protein dystrophin. Affected boys begin manifesting signs of disease early in life, cease walking at the beginning of the second decade, and usually die by age 20 years. Until treatment of the basic genetic defect is available, medical, surgical, and rehabilitative approaches can be used to maintain patient function and comfort. Corticosteroids, including prednisone and a related compound, deflazacort, have recently been shown to markedly delay the loss of muscle strength and function in boys with Duchenne muscular dystrophy. Surgical release of lower extremity contractures may benefit some patients. Approximately 90% of boys with Duchenne muscular dystrophy will develop severe scoliosis, which is not amenable to control by nonsurgical means such as bracing or adaptive seating. The most effective treatment for severe scoliosis is prevention by intervening with early spinal fusion utilizing segmental instrumentation as soon as curves are ascertained and before the onset of severe pulmonary or cardiac dysfunction.
Insights
Duchenne muscular dystrophy management focuses on maintaining function and comfort. Corticosteroids and early spinal fusion for scoliosis can significantly delay disease progression and improve outcomes for affected boys.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disorder characterized by the absence of dystrophin.
- It leads to progressive muscle degeneration, loss of ambulation in early adolescence, and premature death, typically by age 20.
- Current management focuses on supportive care, as a cure for the underlying genetic defect is not yet available.
Purpose of the Study:
- To review current medical, surgical, and rehabilitative strategies for managing Duchenne muscular dystrophy.
- To highlight the efficacy of corticosteroids in preserving muscle function and strength.
- To emphasize the critical role of early surgical intervention for scoliosis in DMD patients.
Main Methods:
- Review of existing literature on Duchenne muscular dystrophy treatments.
- Analysis of the impact of corticosteroids (prednisone, deflazacort) on muscle strength and function.
- Evaluation of surgical interventions for lower extremity contractures and spinal deformities.
Main Results:
- Corticosteroids have demonstrated a significant ability to delay muscle strength and function loss in boys with DMD.
- Surgical release of contractures can offer functional benefits to select patients.
- Early spinal fusion with segmental instrumentation is the most effective treatment for severe scoliosis, preventing pulmonary and cardiac complications.
Conclusions:
- While a definitive cure for DMD remains elusive, a multi-faceted approach is crucial for patient care.
- Pharmacological interventions like corticosteroids and timely surgical management, particularly for scoliosis, can substantially improve quality of life and prolong survival.
- Proactive management of scoliosis is essential to prevent severe respiratory and cardiac compromise in DMD patients.